Eluxadoline is a medication taken by mouth for the treatment of diarrhea and abdominal pain in individuals with diarrhea-predominant irritable bowel syndrome (IBS-D).
This report contains market size and forecasts of Eluxadoline API in global, including the following market information:
Global Eluxadoline API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Eluxadoline API Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Eluxadoline API companies in 2021 (%)
The global Eluxadoline API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Eluxadoline API include Tecoland, FCDA, Teva Pharmaceutical Industries, Pharmaffiliates, Clearsynth, Jigs chemical, Shijiazhuang Dingmin Pharmaceutical Sciences, CoreSyn and Sjar-tech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Eluxadoline API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Eluxadoline API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Eluxadoline API Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Eluxadoline API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Eluxadoline API Market Segment Percentages, by Application, 2021 (%)
Research
Pharmaceutical
Global Eluxadoline API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Eluxadoline API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Eluxadoline API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Eluxadoline API revenues share in global market, 2021 (%)
Key companies Eluxadoline API sales in global market, 2017-2022 (Estimated), (MT)
Key companies Eluxadoline API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Tecoland
FCDA
Teva Pharmaceutical Industries
Pharmaffiliates
Clearsynth
Jigs chemical
Shijiazhuang Dingmin Pharmaceutical Sciences
CoreSyn
Sjar-tech
Widely
Sichuan CheCo Pharmaceutical Technology